Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,831,528
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1,065,912
-
Shares change
-
+1,065,894
-
Total reported value, excl. options
-
$2,076,645
-
Value change
-
+$2,076,610
-
Number of buys
-
17
-
Price
-
$1.95
Significant Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q4 2022
18 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,065,912 shares
of 13,831,528 outstanding shares and own 7.71% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (420,710 shares), VANGUARD GROUP INC (271,445 shares), RENAISSANCE TECHNOLOGIES LLC (114,028 shares), BlackRock Inc. (74,063 shares), GEODE CAPITAL MANAGEMENT, LLC (69,534 shares), MORGAN STANLEY (44,694 shares), STATE STREET CORP (24,443 shares), Parallel Advisors, LLC (15,228 shares), NORTHERN TRUST CORP (12,207 shares), and BANK OF AMERICA CORP /DE/ (8,991 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.